5-161701908-C-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000811.3(GABRA6):​c.*135C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.53 in 938,038 control chromosomes in the GnomAD database, including 134,921 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.50 ( 19695 hom., cov: 32)
Exomes 𝑓: 0.53 ( 115226 hom. )

Consequence

GABRA6
NM_000811.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.520

Publications

49 publications found
Variant links:
Genes affected
GABRA6 (HGNC:4080): (gamma-aminobutyric acid type A receptor subunit alpha6) GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. At least 16 distinct subunits of GABA-A receptors have been identified. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 5-161701908-C-T is Benign according to our data. Variant chr5-161701908-C-T is described in ClinVar as Benign. ClinVar VariationId is 1169913.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.564 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000811.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRA6
NM_000811.3
MANE Select
c.*135C>T
3_prime_UTR
Exon 9 of 9NP_000802.2Q16445

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRA6
ENST00000274545.10
TSL:1 MANE Select
c.*135C>T
3_prime_UTR
Exon 9 of 9ENSP00000274545.5Q16445
GABRA6
ENST00000523217.5
TSL:5
c.*135C>T
3_prime_UTR
Exon 9 of 9ENSP00000430527.1E7EV53
GABRA6
ENST00000521520.1
TSL:2
n.1490C>T
non_coding_transcript_exon
Exon 3 of 3

Frequencies

GnomAD3 genomes
AF:
0.505
AC:
76609
AN:
151838
Hom.:
19691
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.442
Gnomad AMI
AF:
0.435
Gnomad AMR
AF:
0.447
Gnomad ASJ
AF:
0.527
Gnomad EAS
AF:
0.306
Gnomad SAS
AF:
0.431
Gnomad FIN
AF:
0.554
Gnomad MID
AF:
0.497
Gnomad NFE
AF:
0.568
Gnomad OTH
AF:
0.489
GnomAD4 exome
AF:
0.534
AC:
420094
AN:
786082
Hom.:
115226
Cov.:
10
AF XY:
0.532
AC XY:
217033
AN XY:
407704
show subpopulations
African (AFR)
AF:
0.444
AC:
8623
AN:
19412
American (AMR)
AF:
0.368
AC:
12690
AN:
34530
Ashkenazi Jewish (ASJ)
AF:
0.536
AC:
10681
AN:
19940
East Asian (EAS)
AF:
0.312
AC:
10653
AN:
34120
South Asian (SAS)
AF:
0.447
AC:
28514
AN:
63846
European-Finnish (FIN)
AF:
0.546
AC:
20210
AN:
37046
Middle Eastern (MID)
AF:
0.498
AC:
1576
AN:
3166
European-Non Finnish (NFE)
AF:
0.573
AC:
307264
AN:
536192
Other (OTH)
AF:
0.526
AC:
19883
AN:
37830
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
9731
19462
29193
38924
48655
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5718
11436
17154
22872
28590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.504
AC:
76629
AN:
151956
Hom.:
19695
Cov.:
32
AF XY:
0.502
AC XY:
37248
AN XY:
74252
show subpopulations
African (AFR)
AF:
0.442
AC:
18313
AN:
41438
American (AMR)
AF:
0.447
AC:
6818
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.527
AC:
1830
AN:
3472
East Asian (EAS)
AF:
0.306
AC:
1578
AN:
5162
South Asian (SAS)
AF:
0.430
AC:
2072
AN:
4816
European-Finnish (FIN)
AF:
0.554
AC:
5837
AN:
10542
Middle Eastern (MID)
AF:
0.500
AC:
147
AN:
294
European-Non Finnish (NFE)
AF:
0.568
AC:
38617
AN:
67946
Other (OTH)
AF:
0.484
AC:
1022
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1961
3922
5882
7843
9804
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
672
1344
2016
2688
3360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.542
Hom.:
86587
Bravo
AF:
0.490
Asia WGS
AF:
0.345
AC:
1201
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Childhood absence epilepsy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
5.3
DANN
Benign
0.77
PhyloP100
0.52
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3219151; hg19: chr5-161128914; COSMIC: COSV50878678; API